Trade Relay Therapeutics, Inc. - RLAY CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.06 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.05 |
| Open | 4.14 |
| 1-Year Change | -61.24% |
| Day's Range | 3.9 - 4.17 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 3.90 | -0.18 | -4.41% | 4.08 | 4.21 | 3.89 |
| Feb 20, 2025 | 4.05 | -0.08 | -1.94% | 4.13 | 4.20 | 3.99 |
| Feb 19, 2025 | 4.12 | 0.28 | 7.29% | 3.84 | 4.13 | 3.80 |
| Feb 18, 2025 | 3.87 | -0.15 | -3.73% | 4.02 | 4.16 | 3.87 |
| Feb 14, 2025 | 3.96 | 0.07 | 1.80% | 3.89 | 4.13 | 3.82 |
| Feb 13, 2025 | 3.92 | 0.32 | 8.89% | 3.60 | 3.92 | 3.60 |
| Feb 12, 2025 | 3.72 | 0.16 | 4.49% | 3.56 | 3.72 | 3.56 |
| Feb 11, 2025 | 3.71 | -0.11 | -2.88% | 3.82 | 3.99 | 3.70 |
| Feb 10, 2025 | 4.00 | -0.14 | -3.38% | 4.14 | 4.16 | 3.98 |
| Feb 7, 2025 | 4.19 | -0.34 | -7.51% | 4.53 | 4.53 | 4.14 |
| Feb 6, 2025 | 4.48 | -0.21 | -4.48% | 4.69 | 4.80 | 4.48 |
| Feb 5, 2025 | 4.76 | 0.24 | 5.31% | 4.52 | 4.83 | 4.52 |
| Feb 4, 2025 | 4.58 | 0.22 | 5.05% | 4.36 | 4.62 | 4.32 |
| Feb 3, 2025 | 4.43 | 0.18 | 4.24% | 4.25 | 4.57 | 4.21 |
| Jan 31, 2025 | 4.44 | -0.02 | -0.45% | 4.46 | 4.65 | 4.40 |
| Jan 30, 2025 | 4.51 | 0.12 | 2.73% | 4.39 | 4.62 | 4.35 |
| Jan 29, 2025 | 4.45 | -0.03 | -0.67% | 4.48 | 4.63 | 4.38 |
| Jan 28, 2025 | 4.59 | 0.06 | 1.32% | 4.53 | 4.74 | 4.33 |
| Jan 27, 2025 | 4.69 | 0.03 | 0.64% | 4.66 | 5.01 | 4.65 |
| Jan 24, 2025 | 4.83 | 0.19 | 4.09% | 4.64 | 4.97 | 4.56 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Relay Therapeutics, Inc. Company profile
About Relay Therapeutics Inc
Relay Therapeutics Inc. is a clinical-stage precision medicines company. The Company is focused on transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The Company is advancing a pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008, RLY-2608 and RLY-1971. Its RLY-1971 binds and stabilizes Src homology region two (SH2)-containing protein tyrosine phosphatase two (SHP2) in its inactive conformation. Its RLY-4008, is it inhibitor of fibroblast growth factor receptor 2 (FGFR2), enriched for patients with advanced solid tumors having oncogenic FGFR2. The Company uses its Dynamo platform to focus on precision oncology. It is also advancing several early programs focused on other precision oncology and genetic disease targets.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Relay Therapeutics Inc revenues decreased 96% to $3M. Net loss applicable to common stockholders increased 58% to $363.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects General and ad increase of 60% to $33M (expense), Stock-based Compensation in R&D increase of 70% to $24.9M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
399 Binney Street
2nd Floor
CAMBRIDGE
MASSACHUSETTS 02139
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com